Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Cytoskeletal and Stem Cell Research

Executive Summary: Y-27632 dihydrochloride (APExBIO, A3008) is a potent and selective inhibitor of Rho-associated protein kinases ROCK1 and ROCK2, exhibiting IC₅₀ values of 140 nM and a K_i of 300 nM, respectively, with >200-fold selectivity over related kinases (APExBIO, product page). It disrupts Rho-mediated stress fiber formation, modulates cell cycle progression, and inhibits cytokinesis (Zhang et al., 2025, DOI). Y-27632 enhances stem cell viability in human and animal models, supporting organoid growth and tissue engineering workflows. In cancer studies, it reduces tumor cell invasion and metastasis in vivo. The compound is soluble in DMSO, ethanol, and water, with recommended storage below -20°C for stock solutions.

Biological Rationale

Rho-associated protein kinases, ROCK1 and ROCK2, are serine/threonine kinases that regulate actin cytoskeleton organization, cell shape, and motility. Their activity is essential for the formation of actin stress fibers and focal adhesions in non-muscle cells (Zhang et al., 2025). Dysregulation of Rho/ROCK signaling leads to aberrant cell proliferation, loss of epithelial barrier integrity, and pathological tissue remodeling. ROCK activity also influences the cell cycle, particularly the G1/S transition, and is implicated in the failure of cytokinesis. In the context of intestinal stem cell (ISC) biology, proper cytoskeletal dynamics are critical for crypt architecture and regenerative capacity, processes influenced by ROCK signaling. By selectively inhibiting ROCK1/2, Y-27632 serves as a precise probe for dissecting these mechanisms in health and disease.

Mechanism of Action of Y-27632 dihydrochloride

Y-27632 dihydrochloride is a small-molecule inhibitor that binds competitively to the ATP-binding site of ROCK1 and ROCK2. The compound inhibits ROCK1 with an IC₅₀ of 140 nM and ROCK2 with a K_i of 300 nM, demonstrating high target specificity. Its selectivity exceeds 200-fold when compared to PKC, cAMP-dependent protein kinase, MLCK, and PAK (APExBIO product page). Inhibition of ROCK activity prevents phosphorylation of downstream effectors, such as myosin light chain (MLC), resulting in the dissolution of actin-myosin contractile filaments and disruption of stress fibers. This leads to altered cell morphology, reduced contractility, and impaired cell migration. Y-27632 also affects cell cycle checkpoints, modulates cytokinesis, and can attenuate apoptosis under certain conditions.

Evidence & Benchmarks

• Y-27632 dihydrochloride inhibits ROCK1 (IC₅₀ = 140 nM) and ROCK2 (K_i = 300 nM) in kinase assays, with >200-fold selectivity over PKC, MLCK, and PAK (APExBIO).
• In prostatic smooth muscle cells in vitro, Y-27632 reduces cell proliferation in a concentration-dependent manner at 1–10 μM concentrations (Zhang et al., 2025).
• In mouse xenograft models, Y-27632 administration reduces tumor invasion and metastasis, as measured by histopathology and metastatic burden (Zhang et al., 2025).
• In human intestinal organoid cultures, Y-27632 supports stem cell viability and maintenance of crypt-like structures, particularly under stress or during passaging (Zhang et al., 2025).
• Y-27632 enables efficient expansion of human pluripotent stem cells by preventing dissociation-induced apoptosis (previously reported in hESC and hiPSC systems; see this review for workflow details).

Applications, Limits & Misconceptions

Y-27632 dihydrochloride is widely used in cellular and molecular biology for:

• Stem cell research: Enhances viability of dissociated human embryonic and induced pluripotent stem cells (hESCs/iPSCs), facilitating single-cell passaging and organoid formation (Zhang et al., 2025).
• Cancer research: Inhibits tumor invasion, metastasis, and modulates the tumor microenvironment in preclinical models.
• Cytoskeletal studies: Disrupts Rho-mediated stress fiber formation, allowing analysis of actin dynamics and cell migration.
• Cell cycle and cytokinesis assays: Enables dissection of G1/S progression and abscission mechanisms.

This article extends Y-27632 Dihydrochloride: Selective ROCK Inhibitor for Advanced Cell Modeling by providing quantitative IC₅₀ and K_i data and clarifying solubility and storage parameters. For a strategic translational context, Strategic ROCK Inhibition in Translational Research focuses on clinical applications and induced pluripotent stem cell modeling, while the present article details molecular selectivity benchmarks and caveats.

Common Pitfalls or Misconceptions

• Y-27632 does not inhibit non-ROCK kinases at concentrations <10 μM; off-target effects are rare but possible at higher doses.
• It does not reverse aging of intestinal stem cells directly; instead, it supports maintenance and survival during culture (Zhang et al., 2025).
• Prolonged exposure to Y-27632 (>72 hours) can result in adaptive changes or reduced efficacy in some cell lines.
• It is not a substitute for growth factors in organoid culture media; ROCK inhibition complements, but does not replace, essential niche signals.
• Y-27632 does not act as an antioxidant or mTOR inhibitor and should not be confused with agents like α-lipoic acid or rapamycin.

Workflow Integration & Parameters

Y-27632 dihydrochloride is supplied as a solid by APExBIO and should be stored desiccated at 4°C or below. It is soluble at ≥111.2 mg/mL in DMSO, ≥17.57 mg/mL in ethanol, and ≥52.9 mg/mL in water. Warming to 37°C or brief sonication can expedite dissolution. Stock solutions are stable below -20°C for up to several months, but repeated freeze-thaw cycles should be avoided. In vitro, working concentrations typically range from 1 to 20 μM depending on cell type and assay. For stem cell passaging, 10 μM is commonly used for 24–48 hours post-dissociation. In in vivo studies, dosing protocols vary and require pharmacokinetic validation. Always consult primary literature for application-specific parameters.

For troubleshooting and advanced comparative insights, Y-27632 Dihydrochloride: Precision ROCK Inhibition for Cytoskeletal Modeling provides detailed workflows and troubleshooting strategies. This article updates those parameters with the latest evidence on storage and solubility.

Conclusion & Outlook

Y-27632 dihydrochloride remains the benchmark selective ROCK inhibitor for dissecting Rho/ROCK signaling in cell biology, stem cell, and cancer research. Its high potency, solubility, and selectivity make it a core reagent for reproducible and interpretable studies. Future work will further define its role in tissue engineering and regenerative medicine. For full specifications and ordering, see the APExBIO Y-27632 dihydrochloride product page.